Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis
- James W. Verbsky
- , Andrew J. White
Research output: Contribution to journal › Article › peer-review
168
Link opens in a new tab
Scopus
citations